![Robert Dufour](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Dufour
Keine laufenden Positionen mehr
Karriereverlauf von Robert Dufour
Ehemalige bekannte Positionen von Robert Dufour
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VELOXIS PHARMACEUTICALS A/S | Vertrieb & Marketing | 03.06.2014 | - |
AUXILIUM PHARMACEUTICALS, INC. | Vertrieb & Marketing | - | - |
Statistik
International
Vereinigte Staaten | 2 |
Dänemark | 2 |
Operativ
Sales & Marketing | 2 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Auxilium Pharmaceuticals LLC
![]() Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
Veloxis Pharmaceuticals A/S
![]() Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Börse
- Insiders
- Robert Dufour
- Erfahrung